Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed)

National Institutes of Health · HHS

CFDA Numbers

93.279

Award Ceiling

—

Award Floor

—

Expected Awards

Close Date

Sep 30, 2026

Section I

How to Apply

View on grants_gov ↗

Program Contact

Tam Nguyen, PhD<br/>nidagmbemail@nida.nih.gov
nidagmbemail@nida.nih.gov

Section II

Eligibility

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Eligible Applicant Types

00, 01, 02, 04, 05, 06, 07, 08, 11, 12, 13, 20, 22, 23, 25

Section III

Description

The purpose of this notice of funding opportunity (NOFO) is to establish a Center that trains researchers in formal product development for new substance use disorder (SUD) pharmacotherapeutics and to advance the best concepts through initial experiments via technical and financial support.

Section IV

Key Dates

Posted: May 21, 2026
Closes: Sep 30, 2026
Archive: Nov 30, 2026